Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

21.64
BATS BZX Real-Time Price
As of 3:11pm ET
 -0.07 / -0.32%
Today’s Change
12.51
Today|||52-Week Range
22.17
+15.35%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close21.71
Today’s open21.67
Day’s range21.63 - 21.71
Volume171,705
Average volume (3 months)1,149,472
Market cap$932.1M
Dividend yield--
Data as of 3:11pm ET, 06/27/2017

Growth & Valuation

Earnings growth (last year)-2,514.29%
Earnings growth (this year)+18.95%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+41.36%
P/E ratioNM
Price/Sales1.26
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...+0.19+5.65%
RGNXRegenxbio Inc-1.28-5.59%
MEDPMedpace Holdings Inc-0.27-0.93%
BSTCBiospecifics Technol...-1.60-3.19%
Data as of 3:15pm ET, 06/27/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$568.8M
Annual profit (last year)-$70.2M
Net profit margin-12.34%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts